157 related articles for article (PubMed ID: 35243143)
1. A case of conjunctival precursor T cell lymphoblastic lymphoma presenting with salmon colored conjunctival mass.
Sugawara R; Usui Y; Takahashi R; Nagao T; Goto H
Am J Ophthalmol Case Rep; 2022 Mar; 25():101382. PubMed ID: 35243143
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
3. [Mediastinal T lymphoblastic lymphoma/leukemia: clinicopathological and prognostic analyses of 61 cases].
Gao XZ; Wei JG; Li SL; Han J; Wang GN; Li WC
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):601-606. PubMed ID: 32486538
[No Abstract] [Full Text] [Related]
4. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous involvement in lymphoblastic lymphoma.
Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
[TBL] [Abstract][Full Text] [Related]
6. Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient.
Brčić I; Labar B; Perić-Balja M; Bašić-Kinda S; Nola M
Int J Hematol; 2008 Sep; 88(2):189-191. PubMed ID: 18512118
[TBL] [Abstract][Full Text] [Related]
7. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
Lin P; Jones D; Dorfman DM; Medeiros LJ
Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Survival after T-cell Lymphoblastic Lymphoma Treated with One Cycle of Hyper-CVAD Regimen.
Ryu IH; Cho IS; Ryu AJ; Kim MG; Jeon JW; Kim JS; Lee JJ; Choi JW; Kang DW
Cancer Res Treat; 2015 Jan; 47(1):115-9. PubMed ID: 25152191
[TBL] [Abstract][Full Text] [Related]
9. An unusual presentation of precursor T cell lymphoblastic leukemia/lymphoma with cholestatic jaundice: case report.
Patel KJ; Latif SU; de Calaca WM
J Hematol Oncol; 2009 Mar; 2():12. PubMed ID: 19284608
[TBL] [Abstract][Full Text] [Related]
10. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
Terada T
Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
[TBL] [Abstract][Full Text] [Related]
11. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
[TBL] [Abstract][Full Text] [Related]
12. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.
Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
[TBL] [Abstract][Full Text] [Related]
13. Terminal deoxynucleotidyl transferase (TdT)-negative T-cell lymphoblastic lymphoma with loss of the T-cell lineage-specific marker CD3 at relapse: a rare entity with an aggressive outcome.
Hassan M; Abdullah HMA; Wahid A; Qamar MA
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29884716
[TBL] [Abstract][Full Text] [Related]
14. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
15. T-lymphoblastic lymphoma/leukemia without clonal
Wang J; Jiang S; Zhao Q; Wei X; Li W
Transl Cancer Res; 2021 Mar; 10(3):1603-1608. PubMed ID: 35116486
[TBL] [Abstract][Full Text] [Related]
16. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
17. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.
Dabaja BS; Ha CS; Thomas DA; Wilder RB; Gopal R; Cortes J; Bueso-Ramos C; Hess MA; Cox JD; Kantarjian HM
Cancer; 2002 May; 94(10):2738-44. PubMed ID: 12173345
[TBL] [Abstract][Full Text] [Related]
18. Role of Allogeneic HCT as Postremission Therapy for Transplant-Eligible Adult Lymphoblastic Leukemia/Lymphoma After Frontline Hyper-CVAD.
Damlaj M; Snnallah M; Bashir R; Eddine IS; Alahmari B; Salama H; Alaskar A; Alhejazi A; Alzahrani M
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):690-696. PubMed ID: 32636149
[TBL] [Abstract][Full Text] [Related]
19. Mantle cell lymphoma diagnosed by conjunctival salmon-pink lesion biopsy.
Matsuo T; Ichimura K; Kubonishi S
J Clin Exp Hematop; 2014; 54(2):143-7. PubMed ID: 25318947
[TBL] [Abstract][Full Text] [Related]
20. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
Morita K; Jain N; Kantarjian H; Takahashi K; Fang H; Konopleva M; El Hussein S; Wang F; Short NJ; Maiti A; Sasaki K; Garcia-Manero G; Konoplev S; Ravandi F; Khoury JD; Jabbour E
Am J Hematol; 2021 May; 96(5):589-598. PubMed ID: 33639000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
